Butterfly Network (BFLY) EBT Growth (1y) (2021 - 2026)
Butterfly Network (BFLY) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 17.94% |
| 10 | Butterfly Network | 2.43 Bn | 2.30 Bn | 23.29 Mn | 6.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.54% |
| Mar 31, 2026 | 9.19% |
| Dec 31, 2025 | 16.40% |
| Sep 30, 2025 | -101.32% |
| Jun 30, 2025 | 11.95% |
| Mar 31, 2025 | 35.84% |
| Dec 31, 2024 | 58.72% |
| Sep 30, 2024 | 38.37% |
| Jun 30, 2024 | 45.29% |
| Mar 31, 2024 | 34.96% |
| Dec 31, 2023 | -30.81% |
| Sep 30, 2023 | 49.98% |
| Jun 30, 2023 | 19.85% |
| Mar 31, 2023 | 24.76% |
| Dec 31, 2022 | -116.42% |
| Sep 30, 2022 | -303.38% |
| Jun 30, 2022 | -1,137.56% |
| Mar 31, 2022 | -6,575.68% |
| Dec 31, 2021 | 32.05% |
| Sep 30, 2021 | 85.29% |